Literature DB >> 11866302

Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis.

Abdullah Sonsuz, Metin Basaranoglu, Muammer Bilir, Hakan Senturk, Perihan Akin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11866302     DOI： 10.1111/j.1572-0241.2002.05510.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.

Authors:  Reona Morio; Hideyuki Hyogo; Masahiro Hatooka; Kei Morio; Hiromi Kan; Tomoki Kobayashi; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Hidenori Ochi; Yoneda Masayasu; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2016-06-28       Impact factor: 7.527

3.  Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males.

Authors:  Rui Wang; Qiang Lu; Ji Feng; Fuzai Yin; Chunmei Qin; Bo Liu; Yali Liu; Xiaoli Liu
Journal:  Endocrine       Date:  2011-07-28       Impact factor: 3.633

4.  Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives.

Authors:  Metin Basaranoglu; Billur Canbakan; Kemal Yildiz; Bahadir Ceylan; Birol Baysal; Omer Uysal; Hakan Senturk
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

Review 5.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

6.  Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.

Authors:  Motoi Hashiba; Masafumi Ono; Hideyuki Hyogo; Yukio Ikeda; Kosei Masuda; Reiko Yoshioka; Yoichi Ishikawa; Yuri Nagata; Kensuke Munekage; Tsunehiro Ochi; Akira Hirose; Yasuko Nozaki-Fujimura; Shuhei Noguchi; Nobuto Okamoto; Kazuaki Chayama; Narufumi Suganuma; Toshiji Saibara
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

7.  Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?

Authors:  Parisa Shabani; H Naeimi Khaledi; Maani Beigy; Solaleh Emamgholipour; Eskandar Parvaz; Hossein Poustchi; Mahmood Doosti
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

8.  Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.

Authors:  Yusuke Oki; Masafumi Ono; Hideyuki Hyogo; Tsunehiro Ochi; Kensuke Munekage; Yasuko Nozaki; Akira Hirose; Kosei Masuda; Hiroshi Mizuta; Nobuto Okamoto; Toshiji Saibara
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-07       Impact factor: 2.566
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.